Shopping Cart 0
Cart Subtotal
AED 0

Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Progenics Pharmaceuticals (Progenics or 'the company') is a biopharmaceutical company focused on the development of medicines and products including therapeutic agents and imaging agents for targeting and treating cancer. The company operates in the US, where it is headquartered in New York.

Scope

- Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Progenics Pharmaceuticals, Inc.: Company Overview 9

Progenics Pharmaceuticals, Inc.: Overview and Key Facts 9

Progenics Pharmaceuticals, Inc.: Overview 9

Progenics Pharmaceuticals, Inc.: Key Facts 9

Progenics Pharmaceuticals, Inc.: Key Employees 11

Progenics Pharmaceuticals, Inc.: Key Employee Biographies 12

Progenics Pharmaceuticals, Inc.: Major Products and Services 17

Progenics Pharmaceuticals, Inc.: Company History 18

Progenics Pharmaceuticals, Inc.: Management Statement 21

Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries 24

Progenics Pharmaceuticals, Inc.: Key Competitors 25

Progenics Pharmaceuticals, Inc.: Company Analysis 26

Progenics Pharmaceuticals, Inc.: Business Description 26

Progenics Pharmaceuticals, Inc.: SWOT Analysis 27

Progenics Pharmaceuticals, Inc.: SWOT Overview 27

Progenics Pharmaceuticals, Inc.: Strengths 27

Progenics Pharmaceuticals, Inc.: Weaknesses 28

Progenics Pharmaceuticals, Inc.: Opportunities 28

Progenics Pharmaceuticals, Inc.: Threats 29

Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity 32

Progenics Pharmaceuticals, Inc.: Financial Deals Overview 32

Progenics Pharmaceuticals, Inc.: Targets and Partners 33

Progenics Pharmaceuticals, Inc.: Top Deals 2014-2018YTD* 34

Progenics Pharmaceuticals, Inc.: Advisors 35

Progenics Pharmaceuticals, Inc.: Top Legal Advisors 35

Progenics Pharmaceuticals, Inc.: Top Financial Advisors 35

Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions 36

Progenics Pharmaceuticals, Inc.: Capital Raising 37

Progenics Pharmaceuticals, Inc.: Partnership 38

Progenics Pharmaceuticals, Inc.: Recent Developments 39

Progenics Pharmaceuticals, Inc.: News and Events Summary 39

Progenics Pharmaceuticals, Inc.: Financial Performance 42

Progenics Pharmaceuticals, Inc.: Market Developments 43

Progenics Pharmaceuticals, Inc.: Research & Development 46

Appendix 47

Contact Us 47

Methodology 47

About MarketLine 48


List Of Figure

List of Figures

Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 2: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size-Value (USUSDm)

Figure 3: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Figure 4: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2014-YTD*2018)

Figure 5: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Figure 6: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Figure 7: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 8: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Progenics Pharmaceuticals, Inc.: Key Facts

Table 2: Progenics Pharmaceuticals, Inc.: Key Employees

Table 3: Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Progenics Pharmaceuticals, Inc.: Key Competitors

Table 5: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 6: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size-Value (USUSDm)

Table 7: Progenics Pharmaceuticals, Inc.: Targets and Partners

Table 8: Progenics Pharmaceuticals, Inc.: Top Deals 2014-2018YTD*

Table 9: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (USUSDm)

Table 10: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (USUSDm)

Table 11: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Table 12: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2014-YTD*2018)

Table 13: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Table 15: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 16: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 17: Progenics Pharmaceuticals, Inc.: News and Events Summary

Table 18: Progenics Pharmaceuticals, Inc.: Financial Performance

Table 19: Progenics Pharmaceuticals, Inc.: Market Developments

Table 20: Progenics Pharmaceuticals, Inc.: Research & Development

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Progenics Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Progenics Pharmaceuticals (Progenics or 'the company') is a biopharmaceutical company focused on the development of medicines and products including therapeutic agents and imaging agents for targeting and treating cancer. The company operates in the US, where it is headquartered in New York.

Scope

- Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Progenics Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Progenics Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Progenics Pharmaceuticals, Inc.: Company Overview 9

Progenics Pharmaceuticals, Inc.: Overview and Key Facts 9

Progenics Pharmaceuticals, Inc.: Overview 9

Progenics Pharmaceuticals, Inc.: Key Facts 9

Progenics Pharmaceuticals, Inc.: Key Employees 11

Progenics Pharmaceuticals, Inc.: Key Employee Biographies 12

Progenics Pharmaceuticals, Inc.: Major Products and Services 17

Progenics Pharmaceuticals, Inc.: Company History 18

Progenics Pharmaceuticals, Inc.: Management Statement 21

Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries 24

Progenics Pharmaceuticals, Inc.: Key Competitors 25

Progenics Pharmaceuticals, Inc.: Company Analysis 26

Progenics Pharmaceuticals, Inc.: Business Description 26

Progenics Pharmaceuticals, Inc.: SWOT Analysis 27

Progenics Pharmaceuticals, Inc.: SWOT Overview 27

Progenics Pharmaceuticals, Inc.: Strengths 27

Progenics Pharmaceuticals, Inc.: Weaknesses 28

Progenics Pharmaceuticals, Inc.: Opportunities 28

Progenics Pharmaceuticals, Inc.: Threats 29

Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity 32

Progenics Pharmaceuticals, Inc.: Financial Deals Overview 32

Progenics Pharmaceuticals, Inc.: Targets and Partners 33

Progenics Pharmaceuticals, Inc.: Top Deals 2014-2018YTD* 34

Progenics Pharmaceuticals, Inc.: Advisors 35

Progenics Pharmaceuticals, Inc.: Top Legal Advisors 35

Progenics Pharmaceuticals, Inc.: Top Financial Advisors 35

Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions 36

Progenics Pharmaceuticals, Inc.: Capital Raising 37

Progenics Pharmaceuticals, Inc.: Partnership 38

Progenics Pharmaceuticals, Inc.: Recent Developments 39

Progenics Pharmaceuticals, Inc.: News and Events Summary 39

Progenics Pharmaceuticals, Inc.: Financial Performance 42

Progenics Pharmaceuticals, Inc.: Market Developments 43

Progenics Pharmaceuticals, Inc.: Research & Development 46

Appendix 47

Contact Us 47

Methodology 47

About MarketLine 48


List Of Figure

List of Figures

Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Figure 2: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size-Value (USUSDm)

Figure 3: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Figure 4: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2014-YTD*2018)

Figure 5: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Figure 6: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Figure 7: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Figure 8: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)


List Of Table

List of Tables

Table 1: Progenics Pharmaceuticals, Inc.: Key Facts

Table 2: Progenics Pharmaceuticals, Inc.: Key Employees

Table 3: Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Progenics Pharmaceuticals, Inc.: Key Competitors

Table 5: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD*2018)

Table 6: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size-Value (USUSDm)

Table 7: Progenics Pharmaceuticals, Inc.: Targets and Partners

Table 8: Progenics Pharmaceuticals, Inc.: Top Deals 2014-2018YTD*

Table 9: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (USUSDm)

Table 10: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (USUSDm)

Table 11: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2014-YTD*2018)

Table 12: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2014-YTD*2018)

Table 13: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD*2018)

Table 14: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD*2018)

Table 15: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD*2018)

Table 16: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD*2018)

Table 17: Progenics Pharmaceuticals, Inc.: News and Events Summary

Table 18: Progenics Pharmaceuticals, Inc.: Financial Performance

Table 19: Progenics Pharmaceuticals, Inc.: Market Developments

Table 20: Progenics Pharmaceuticals, Inc.: Research & Development

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS